deltatrials
Unknown NA INTERVENTIONAL 2-arm NCT05050825

Validation of a CDSA Strategy to Reduce Antibiotic Prescription in Senegal

Validation of an Assisted Medical Care Strategy Composed of a Clinical Decision Support System and RDTs to Reduce Antibiotic Prescription in Non-severe Acute Disease in Children 15 Years Old and Younger in Senegal

Sponsor: Foundation for Innovative New Diagnostics, Switzerland

Conditions Acute Febrile Illness Dengue Diarrhea Influenza -Like Illness Malaria Pneumonia
Interventions Patient clinical management based on the CDSA strategy
Updated 6 times since 2021 Last updated: Oct 26, 2021 Started: May 3, 2021 Primary completion: Nov 30, 2021 Completion: Dec 15, 2021
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Acute Febrile Illness and Dengue, this trial is ongoing. The trial is conducted by Foundation for Innovative New Diagnostics, Switzerland and has accumulated 6 data snapshots since 2021. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

~Oct 2021 – ~Nov 2021 · 31 days · monthly snapshotRecruiting~Nov 2021 – ~Oct 2023 · 23 months · monthly snapshotRecruiting~Oct 2023 – ~Jul 2024 · 9 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotUnknown~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotUnknown~Sep 2025 – present · 11 months · monthly snapshotUnknown

Change History

6 versions recorded

  1. Sep 2025 — Present [monthly]

    Unknown NA

  2. Sep 2024 — Sep 2025 [monthly]

    Unknown NA

  3. Jul 2024 — Sep 2024 [monthly]

    Unknown NA

    Status: Unknown Status → Unknown

  4. Oct 2023 — Jul 2024 [monthly]

    Unknown Status NA

    Status: Recruiting → Unknown Status

  5. Nov 2021 — Oct 2023 [monthly]

    Recruiting NA

▶ Show 1 earlier version

  1. Oct 2021 — Nov 2021 [monthly]

    Recruiting NA

    First recorded

May 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Foundation for Innovative New Diagnostics, Switzerland
  • Institut Pasteur de Dakar
  • Ministry of Health, Senegal
Data source: Foundation for Innovative New Diagnostics, Switzerland

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations